Indium (In111) Chloride Curium Netherlands

Indium-111 chloride, the active ingredient in Indium (In111) Chloride Curium Netherlands, is a radiopharmaceutical presented as a solution for injection for intravenous use. It is used for scintigraphic imaging of inflammation, infection, tumor localization and lymphatic mapping in adult patients.

GNH USA supplies Indium (In111) Chloride Curium Netherlands as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and diagnostic imaging clinics worldwide.

Indium-111 chloride is employed in nuclear medicine for diagnostic imaging of inflammatory, infectious and oncologic conditions. - Scintigraphic imaging of inflammation and infection: enables visualization of inflammatory foci and infectious sites. - Tumor localization and staging: assists in detecting and staging malignant lesions. - Lymphoscintigraphy: facilitates mapping of lymphatic drainage and sentinel node identification.

Adverse reactions may occur following administration of Indium-111 chloride.

Common Side Effects: - Injection site pain: mild discomfort at the site of injection. - Transient flushing: brief sensation of warmth or redness. - Mild nausea: occasional upset stomach. - Headache: mild to moderate headache.

Serious or Rare Side Effects: - Allergic reaction (anaphylaxis): severe hypersensitivity requiring immediate medical attention. - Severe hypotension: marked drop in blood pressure. - Radiation‑induced tissue injury: rare localized damage from radiation exposure.

When using Indium-111 chloride, consider the following precautions. - Pregnancy: unknown safety; avoid unless essential for maternal health. - Breastfeeding: insufficient data; weigh potential risks to the infant. - Renal impairment: monitor as excretion may be reduced, adjust imaging schedule if needed. - Concurrent radiopharmaceuticals: avoid overlapping studies to prevent image interference. - Radiation safety: follow ALARA principles to protect staff and patient from unnecessary exposure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential interactions with other agents should be reviewed before administration.

Major Interactions (Avoid): - Other gamma‑emitting radiopharmaceuticals: may cause image overlap and increased radiation dose. - High‑dose chemotherapeutic agents causing bone marrow suppression: can exacerbate hematologic toxicity.

Moderate Interactions (Monitor Closely): - Iodinated contrast agents used in CT: may alter biodistribution and affect image interpretation. - Beta‑blockers: may mask radiation‑induced tachycardia. - Antihistamines: could reduce observable hypersensitivity signs.